Verfügbarkeit: Das Blaue Buch

Das Blaue Buch: Chemotherapie-Manual Hämatologie und internistische Onkologie ; mit CD-ROM

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Engelhardt, Monika 1966- (VerfasserIn), Berger, Dietmar Paul (VerfasserIn), Mertelsmann, Roland 1944- (VerfasserIn)
Format:	Buch
Sprache:	German
Veröffentlicht:	Berlin [u.a.] Springer 2012
Ausgabe:	4. Aufl.
Schlagworte:	Antineoplastic Protocols Neoplasms - drug therapy Antineoplastic Agents - therapeutic use Hematologic Neoplasms - drug therapy CD-ROM Neoplasms > drug therapy Antineoplastic Agents > therapeutic use Cytostatikum Hämatologie Krebs > Medizin Chemotherapie Onkologie
Online-Zugang:	Inhaltstext Inhaltsverzeichnis
Beschreibung:	XXIV, 215 S. Ill., graph. Darst. 1 CD-ROM (12 cm)
ISBN:	9783642206252 3642206255

Internformat

MARC


LEADER	00000nam a2200000 c 4500
001	BV040132483
003	DE-604
005	20130725
007	t
008	120514s2012 ad\|\| \|\|\|\| 00\|\|\| ger d
015			\|a 11,N24 \|2 dnb
016	7		\|a 1012630765 \|2 DE-101
020			\|a 9783642206252 \|9 978-3-642-20625-2
020			\|a 3642206255 \|9 3-642-20625-5
024	3		\|a 9783642206252
035			\|a (OCoLC)794526237
035			\|a (DE-599)DNB1012630765
040			\|a DE-604 \|b ger \|e rakwb
041	0		\|a ger
049			\|a DE-355
082	0		\|a 616.994061 \|2 22/ger
084			\|a XH 3209 \|0 (DE-625)152888:12915 \|2 rvk
084			\|a QZ 267 \|2 nlm
084			\|a 610 \|2 sdnb
084			\|a 840 \|2 rpb
100	1		\|a Engelhardt, Monika \|d 1966- \|e Verfasser \|0 (DE-588)113263538 \|4 aut
245	1	0	\|a Das Blaue Buch \|b Chemotherapie-Manual Hämatologie und internistische Onkologie ; mit CD-ROM \|c Monika Engelhardt ; Dietmar Berger ; Roland Mertelsmann
250			\|a 4. Aufl.
264		1	\|a Berlin [u.a.] \|b Springer \|c 2012
300			\|a XXIV, 215 S. \|b Ill., graph. Darst. \|e 1 CD-ROM (12 cm)
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
650		2	\|a Antineoplastic Protocols
650		2	\|a Neoplasms - drug therapy
650		2	\|a Antineoplastic Agents - therapeutic use
650		2	\|a Hematologic Neoplasms - drug therapy
650		2	\|a CD-ROM
650		2	\|a Antineoplastic Protocols
650		2	\|a Neoplasms \|a drug therapy
650		2	\|a Antineoplastic Agents \|a therapeutic use
650	0	7	\|a Cytostatikum \|0 (DE-588)4068347-3 \|2 gnd \|9 rswk-swf
650	0	7	\|a Hämatologie \|0 (DE-588)4022796-0 \|2 gnd \|9 rswk-swf
650	0	7	\|a Krebs \|g Medizin \|0 (DE-588)4073781-0 \|2 gnd \|9 rswk-swf
650	0	7	\|a Chemotherapie \|0 (DE-588)4127083-6 \|2 gnd \|9 rswk-swf
650	0	7	\|a Onkologie \|0 (DE-588)4075658-0 \|2 gnd \|9 rswk-swf
689	0	0	\|a Onkologie \|0 (DE-588)4075658-0 \|D s
689	0	1	\|a Hämatologie \|0 (DE-588)4022796-0 \|D s
689	0	2	\|a Chemotherapie \|0 (DE-588)4127083-6 \|D s
689	0	3	\|a Cytostatikum \|0 (DE-588)4068347-3 \|D s
689	0		\|8 1\p \|5 DE-604
689	1	0	\|a Onkologie \|0 (DE-588)4075658-0 \|D s
689	1	1	\|a Hämatologie \|0 (DE-588)4022796-0 \|D s
689	1	2	\|a Chemotherapie \|0 (DE-588)4127083-6 \|D s
689	1	3	\|a Krebs \|g Medizin \|0 (DE-588)4073781-0 \|D s
689	1		\|8 2\p \|5 DE-604
700	1		\|a Berger, Dietmar Paul \|e Verfasser \|0 (DE-588)111674808 \|4 aut
700	1		\|a Mertelsmann, Roland \|d 1944- \|e Verfasser \|0 (DE-588)122802187 \|4 aut
856	4	2	\|m X:MVB \|q text/html \|u http://deposit.dnb.de/cgi-bin/dokserv?id=3838623&prov=M&dok_var=1&dok_ext=htm \|3 Inhaltstext
856	4	2	\|m DNB Datenaustausch \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024989611&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
883	1		\|8 1\p \|a cgwrk \|d 20201028 \|q DE-101 \|u https://d-nb.info/provenance/plan#cgwrk
883	1		\|8 2\p \|a cgwrk \|d 20201028 \|q DE-101 \|u https://d-nb.info/provenance/plan#cgwrk
943	1		\|a oai:aleph.bib-bvb.de:BVB01-024989611

Datensatz im Suchindex

_version_	1805146602930700288
adam_text	IMAGE 1 V I I INHALTSVERZEICHNIS ALLGEMEINES VORWORT Z U R 4. A U F L A G E V A U T O R E N V E R Z E I C H N I S XI A B K UE R Z U N G S V E R Z E I C H N I S XIII E I N L E I T U N G XVII D O S I S M O D I F I K A T I O N S T A B E L L E XXII TEIL I HAEMATOLOGISCHE NEOPLASIEN 1 A K U T E L E U K AE M I E N 3 1.1 ALL G M A L L B - A L L / N H L 2 0 0 2 4 G M A L L 0 7 / 2 0 0 3 7 G M A L L 0 7 / 2 0 0 3 + R I T U X I M A B 1 4 1.2 A M L A P L 0 4 / 0 6 S T U D I E 1 9 AMLSG 11-08 S T U D I E 2 3 A M L S G 1 5 - 1 0 S T U D I E 2 4 A N A L O G A M L SG 0 7 - 0 4 2 5 S-HAM 2 7 IDA/ARA 3 + 7 2 7 IDA/ARA 3 + 4 2 8 MICE 2 8 MINI-ICE 2 9 A Z A C Y T I D I N E ( 3 X 5 0 M G / M 2 ) 3 2 LD-ARAC 2 9 A Z A C Y T I D I N E ( 7 X 7 5 M G / M 2 ) 3 2 2 M Y E L O D Y S P L A S T I S C H E S S Y N D R O M ( M D S ) 3 1 A Z A C Y T I D I N E ( 7 X 7 5 M G / M 2 ) 3 2 A Z A C Y T I D I N E ( 3 X 5 0 M G / M 2 ) 3 2 A T G / C S A / D E C O R T I N 3 3 3 M Y E L O P R O L I F E R A T I V E N E O P L A S I E N ( M P N ) 3 5 3.1 O M F L D T H A L I D O M I D / P R E D N I S O N 3 6 3.2 C M L I M A T I N I B 3 6 CML V S T U D I E 3 7 4 H O D G K I N - L Y M P H O M E 3 9 ABVD 4 0 BEACOPP-IL-BASIS 4 0 BEACOPP-LL-GESTEIGERT 4 1 V I N B L A S T I N 4 1 PVAG 4 2 5 N O N - H O D G K I N - L Y M P H O M E 4 3 5.1 N H L - S T U D I E N GMALL B - A L L / N H L 2 0 0 2 4 M C L - Y O U N G E R - S T U D I E A R M B 5 1 FLYER-STUDIE 5 4 U N F O L D E R - S T U D I E 5 2 CLL 2 0 - S T U D I E 5 6 5 . 2 I N D O L E N T E N H L V O R P H A S E 4 4 C H L O R A M B U C I L / P R E D N I S O N (KNOSPE) 4 4 R-CHOP 5 7 F L U D A R A B I N 4 5 F L U D A R A B I N / C Y C L O P H O S P H A M I D ( M D A N D E R S O N ) 4 5 F L U D A R A B I N / C Y C L O P H O S P H A M I D / R I T U X I M A B (FCR) 4 6 R I T U X I M A B 4 6 B E N D A M U S T I N 4 7 R I T U X I M A B / B E N D A M U S T I N 4 7 A L E M T U Z U M A B 4 8 P E N T O S T A T I N 4 8 R I T U X I M A B / 2 - C D A 4 9 2 - C D A 4 9 PEP-C 5 0 Z E V A L I N / R I T U X I M A B ( A N A L O G S T U D I E ) 5 0 5 . 3 A G G R E S S I V E N H L R-CHOP 5 7 CHOP 5 8 R-CHOP-14 5 8 C H O P - 1 4 5 9 C H O P G E S P L I T T E T 5 9 (R)-CHOEP 14 6 0 R-DHAP 6 0 D H A P 6 1 VACOP-B 6 1 R-ICE 5 7 R I T U X I M A B / B E N D A M U S T I N 4 7 5 . 4 Z N S - N H L H D - M T X / H D - A R A C - T H I O T E P A / H D - B C N U - T H I O T E P A ( F R E I B U R G E R - S T U D I E ) 6 3 LELSG-STUDIE 6 4 R-MPL 6 6 LV RESCUE B O G E N 6 7 5 . 5 M U L T I P L E S M Y E L O M / A M Y L O I D O S E D S M M X I I I - S T U D I E 6 8 M E L P H A L A N / P R E D N I S O N / T H A L I D O M I D 7 0 M E L P H A L A N / P R E D N I S O N / B O R T E Z O M I B 7 1 M P V S T A N D A R D 7 1 M P V A D A P T I E R T 7 1 M E L P H A L A N / P R E D N I S O N / L E N A L I D O M I D 7 2 MPR I N D U K T I O N 7 2 MPR E R H A L T U N G 7 2 B O R T E Z O M I B I.V 7 3 B O R T E Z O M I B S.C 7 3 B O R T E Z O M I B / D E X A M E T H A S O N 7 4 B O R T E Z O M I B / C Y C L O P H O S P H A M I D / D E X A M E T H A S O N 7 4 V C D P.O. S T A N D A R D 7 4 V C D P.O. A D A P T I E R T 7 5 V C D I.V 7 5 B O R T E Z O M I B / M E L P H A L A N / P R E D N I S O N / T H A L I D O M I D 7 6 B O R T E Z O M I B / P E G Y L I E R T - L I P O S O M A L E S D O X O R U B I C I N 7 6 B O R T E Z O M I B / D O X O R U B I C I N / D E X A M E T H A S O N 7 7 B D D S T A N D A R D 7 7 B D D A D A P T I E R T 7 7 B O R T E Z O M I B / L E N A L I D O M I D / D E X A M E T H A S O N 7 8 HTTP://D-NB.INFO/1012630765 IMAGE 2 VIII INHALTSVERZEICHNIS I N D U K T I O N 7 8 E R H A L T U N G 7 8 B O R T E Z O M I B E R H A L T U N G 7 9 T H A L I D O M I D / D E X A M E T H A S O N 7 9 T H A L I D O M I D / P R E D N I S O L O N 8 0 C Y C L O P H O S P H A M I D / T H A L I D O M I D / D E X A M E T H A S O N (CTD) . . . . 8 0 L E N A L I D O M I D / D E X A M E T H A S O N 8 1 L E N A L I D O M I D / C Y C L O P H O S P H A M I D / D E X A - M E T H A S O N 8 2 RCD P.O 8 2 RCD I.V 8 2 M E L P H A L A N / P R E D N I S O N (ALEXANIAN) 8 1 M E L P H A L A N I.V 8 3 B E N D A M U S T I N 4 7 B E N D A M U S T I N / P R E D N I S O L O N / T H A L I D O M I D 8 3 B E N D A M U S T I N / B O R T E Z O M I B / P R E D N I S O L O N ( + T H A L I D O M I D ) . . . . 8 4 V A D 8 4 H D - D E X A M E T H A S O N 8 5 H D - D E X A / I F N A L P H A 8 5 M E L P H A L A N / D E X A M E T H A S O N (PALLADINI-PROTOKOLL) 8 6 6 A P L A S T I S C H E A N AE M I E N 8 7 C Y A / A L G / P R E D N I S O L O N 8 8 7 P A R O X Y S M A L E N AE C H T L I C H E H AE M O G L O B I N U R I E ( P N H ) 8 9 E C U L I Z U M A B 9 0 8 I M M U N T H R O M B O Z Y T O P E N I E 9 1 R O M I P L O S T I M 9 2 TEIL II SOLIDE TUMOREN 9 K O P F - H A L S - T U M O R E N 9 5 D O C E T A X E L / C I S P L A T I N 9 6 D O C E T A X E L / C I S P L A T I N / F L U O R O U R A C I L (TPF) 9 6 D O C E T A X E L W OE C H E N T L I C H 9 7 5 - F U / C I S P L A T I N 9 7 5 - F U / C A R B O P L A T I N 9 8 C E T U X I M A B M O N O T H E R A P I E 9 8 C E T U X I M A B / C I S P L A T I N / 5 - F U 9 9 C E T U X I M A B / C A R B O P L A T I N / 5 - F U 9 9 PACLITAXEL 1 0 0 EMB 1 0 0 P A C L I T A X E L / C I S P L A T I N / I F O S F A M I D (TIP) 101 V I N O R E L B I N 1 4 7 1 0 T H O R A K A L E T U M O R E N 103 10.1 SCLC C I S P L A T I N / E T O P O S I D P H O S P H A T ( L I M I T E D DISEASE) 1 0 4 C A R B O P L A T I N / E T O P O S I D P H O S P H A T 1 0 4 EPICO 105 E T O P O S I D / P A C L I T A X E L / C A R B O P L A T I N (TEC) 105 T O P O T E C A N 1 0 6 L O M U S T I N 1 0 6 L O M U S T I N / M E T H O T R E X A T I I I 1 0 . 2 NSCLC G E M C I T A B I N / C I S P L A T I N 1 0 7 G E M C I T A B I N / C A R B O P L A T I N 1 0 7 V I N O R E L B I N / C I S P L A T I N ( A D J U V A N T ) 1 0 8 V I N O R E L B I N / C A R B O P L A T I N 1 0 8 P A C L I T A X E L / C A R B O P L A T I N 1 0 9 P E M E T R E X E D / C I S P L A T I N 1 0 9 P E M E T R E X E D / C A R B O P L A T I N 110 P E M E T R E X E D 1 1 2 PACLITAXEL W OE C H E N T L I C H / C A R B O P L A T I N 1 1 0 PACLITAXEL W OE C H E N T L I C H 100 D O C E T A X E L I I I D O C E T A X E L W OE C H E N T L I C H 9 7 G E M C I T A B I N 130 V I N O R E L B I N 147 L O M U S T I N / M E T H O T R E X A T I I I 1 0 . 3 P L E U R A M E S O T H E L I O M P A C L I T A X E L / C A R B O P L A T I N / R X 112 G E M C I T A B I N / C I S P L A T I N 107 P E M E T R E X E D / C I S P L A T I N 109 1 0 . 4 T H Y M U S K A R Z I N O M D O X O R U B I C I N / C I S P L A T I N / C Y D O P H O S P H A M I D (PAC) 113 11 G A S T R O I N T E S T I N A L E T U M O R E N 115 11.1 OE S O P H A G U S K A R Z I N O M R X / 5 - F U / C I S P L A T I N ( N A U N H E I M ) 116 5 - F U / C A R B O P L A T I N 9 8 C E T U X I M A B / C I S P L A T I N / 5 - F U 9 9 C E T U X I M A B / C A R B O P L A T I N / 5 - F U 9 9 V I N O R E L B I N 147 D O C E T A X E L 144 EOX 117 1 1 . 2 M A G E N K A R Z I N O M D O C E T A X E L / C I S P L A T I N / F L U O R O U R A C I L (DCF) 116 ECF A M B U L A N T 117 EOX 117 FOLFIRI 121 FLOT 118 T R A S T U Z U M A B / C I S P L A T I N / 5 - F U ( A N A L O G T O G A ) 118 A M B U L A N T 118 S T A T I O N AE R 119 T R A S T U Z U M A B / C I S P L A T I N / C A P E C I T A B I N ( A N A L O G TOGA) 119 1 1 . 3 K O L O N K A R Z I N O M FOLFIRI-BEVACIZUMAB 120 F O L F I R I - C E T U X I M A B 120 FOLFIRI 121 FOLFOX 6 121 FOLFOXIRI 122 FOLFOXIRI-BEVACIZUMAB 122 XELOX 2 123 FOLFOX 4 123 I R I N O T E C A N / C E T U X I M A B 124 C A P E C I T A B I N 124 C A P E C I T A B I N / I R I N O T E C A N (CAPLRI) 125 C A P L R I + B E V A C I Z U M A B 125 F O L F I R I / P A N I T U M U M A B 126 FOLFOX 4 / P A N I T U M U M A B 126 5 - F U / L E U K O V O R I N ( A R D A L A N ) 127 5-FU M O N O ( A D J U V A N T ) 127 I R I N O T E C A N M O N O 128 M I T O M Y C I N - C M O N O 128 P A N I T U M U M A B 129 1 1 . 4 A N A L K A R Z I N O M R X / 5 - F U / M I T O M Y C I N / C I S P L A T I N (NIGRO) 129 1 1 . 5 P A N K R E A S K A R Z I N O M G E M C I T A B I N 130 G E M C I T A B I N / C I S P L A T I N 107 IMAGE 3 INHALTSVERZEICHNIS IX G E M C I T A B I N / C A P E C I T A B I N 1 3 0 G E M C I T A B I N / E R L O T I N I B 131 FOLFIRI 121 FOLFIRINOX 131 FOLFOX 6 1 2 1 5 - F U / L E U K O V O R I N 1 2 7 11.6 C H O L A N G I O Z E L L U L AE R E S K A R Z I N O M G E M O X 3 1 3 2 G E M C I T A B I N / C I S P L A T I N 1 3 2 5 - F U / L E U K O V O R I N 127 SORAFENIB 1 6 8 12 G Y N AE K O L O G I S C H E T U M O R E N 133 12.1 M A M M A K A R Z I N O M 5 - F U / D O X O R U B I C I N / C Y C L O P H O S P H A M I D (FAC) 1 3 4 5 - F U / E P I R U B I C I N / C Y C L O P H O S P H A M I D (FEC) 1 3 4 D O X O R U B I C I N / C Y C L O P H O S P H A M I D (AC) 135 E P I R U B I C I N / C Y C I O P H O S P H A M I D (EC) 135 4XEC - 4 X D O C E T A X E L ( A N A L O G NASBP B27) 1 3 6 3XFEC - 3 X D O C E T A X E L ( A N A L O G PACS 01) 137 AC + PACLITAXEL ( D O S I S D I C H T ) 138 EC + P A C L I T A X E L 138 E P I R U B I C I N - PACLITAXEL - C Y C L O P H O S P H A M I D (ETC) 139 D O C E T A X E L / D O X O R U B I C I N / C Y C L O P H O S P H A M I D (TAC) 1 4 0 EPIRUBICIN/PACLITAXEL (EP) 141 G E M C I T A B I N / C A R B O P L A T I N 141 CMF ( B O N A D O N N A ) 1 4 2 P E G Y L I E R T - L I P O S O M A L E S D O X O R U B I C I N (CAELYX) 1 4 T AE G I G . . . . 155 P E G Y L I E R T - L I P O S O M A L E S D O X O R U B I C I N (CAELYX) 156 E P I R U B I C I N 1 4 2 PACLITAXEL ( W OE C H E N T L I C H ) 143 PACLITAXEL 143 DOCETAXEL 1 4 4 DOCETAXEL ( W OE C H E N T L I C H ) 1 4 4 D O C E T A X E L / C Y C L O P H O S P H A M I D (TC) 145 D O C E T A X E L / T R A S T U Z U M A B 145 D O C E T A X E L / C A R B O P L A T I N / T R A S T U Z U M A B (TCH) 1 4 6 E P I R U B I C I N / D O C E T A X E L 147 V I N O R E L B I N 147 V I N O R E L B I N P.O 1 4 8 T R A S T U Z U M A B ( W OE C H E N T L I C H ) 1 4 8 T R A S T U Z U M A B 1 4 9 P A C L I T A X E L / T R A S T U Z U M A B 1 4 9 G E M C I T A B I N / C I S P L A T I N / T R A S T U Z U M A B 1 5 0 C A P E C I T A B I N / L A P A T I N I B 1 5 0 PACLITAXEL, A L B U M I N - G E B U N D E N (ABRAXANE) 151 12.2 O V A R I A L K A R Z I N O M C A R B O P L A T I N 151 C Y C L O P H O S P H A M I D / C A R B O P L A T I N 1 5 2 PACLITAXEL 143 PACLITAXEL ( W OE C H E N T L I C H ) 143 P A D I T A X E L / C A R B O P L A T I N 1 5 2 G E M C I T A B I N / C A R B O P L A T I N 141 T O P O T E C A N 153 T O P O T E C A N ( W OE C H E N T L I C H ) 153 T O P O T E C A N / B E V A C I Z U M A B 1 5 4 TREOSULFAN 1 5 4 TREOSULFAN ORAL 155 P E G Y L I E R T - L I P O S O M A L E S D O X O R U B I C I N (CAELYX) 1 5 6 P E G Y L I E R T - L I P O S O M A L E S D O X O R U B I C I N 1 4 T AE G I G (CAELYX) . . . . 155 P E G Y L I E R T - L I P O S O M A L E S D O X O R U B I C I N ( C A E L Y X ) / C A R B O P L A T I N . . 1 5 6 G E M C I T A B I N 157 PEB 1 6 2 B E V A C I Z U M A B E R H A L T U N G 157 1 2 . 3 Z E R V I X K A R Z I N O M C I S P L A T I N R A D I O S E N S I T I Z E R 158 T O P O T E C A N / C I S P L A T I N 1 5 8 1 2 . 4 U T E R U S S A R K O M G E M C I T A B I N / D O C E T A X E L ( L E I O M Y O S A R K O M ) 159 1 3 U R O G E N I T A L T U M O R E N 161 13.1 H O D E N K A R Z I N O M PE 1 6 2 PEB 1 6 2 PEI 163 PIV + G-CSF 163 PVB ( C I S P L A T I N / V I N B L A S T I N / B L E O M Y C I N ) 1 6 4 G E M C I T A B I N / O X A L I P L A T I N / P A C L I T A X E L 1 6 4 C A R B O P L A T I N M O N O ( A D J U V A N T ) 165 1 3 . 2 P R O S T A T A K A R Z I N O M D O C E T A X E L / P R E D N I S O L O N 165 D O X O R U B I C I N 1 6 6 M I T O X A N T R O N / P R E D N I S O N 1 6 6 C A B A Z I T A X E L / P R E D N I S O N 167 1 3 . 3 N I E R E N Z E L L K A R Z I N O M S U N I T I N I B 167 S O R A F E N I B 168 H D - I L - 2 / I F N A 1 6 8 T E M S I R O L I M U S 1 6 9 1 3 . 4 P H AE O C H R O M O Z Y T O M C Y C L O P H O S P H A M I D / V I N C R I S T I N / D A C A R B A Z I N 1 6 9 1 3 . 5 U R O T H E L K A R Z I N O M G E M C I T A B I N / C I S P L A T I N 107 M-VAC 1 7 0 V I N F L U N I N 1 7 0 1 4 H A U T T U M O R E N 171 14.1 M E L A N O M C V D 1 7 2 C V D / I L 2 / I F N A (LEGHA) 1 7 2 L E G H A K O N S O L I D I E R U N G 173 D A C A R B A Z I N ( D H C ) M O N O 173 F O T E M U S T I N 1 7 4 L O M U S T I N 1 0 6 I P I L I M U M A B 1 7 4 1 4 . 2 P L A T T E N E P I T H E L K A R Z I N O M E C E T U X I M A B M O N O T H E R A P I E 9 8 1 5 S A R K O M E 175 15.1 W E I C H T E I L S A R K O M D O X O R U B I C I N / C I S P L A T I N / I F O S F A M I D / P A C L I T A X E L 1 7 6 D O X O R U B I C I N / I F O S F A M I D 1 7 6 T R A B E C T E D I N 177 G E M C I T A B I N / D O C E T A X E L 177 G E M C I T A B I N / D O C E T A X E L ( L E I O M Y O S A R K O M ) 1 5 9 1 5 . 2 E W I N G - S A R K O M T O P O T E C A N / C Y C L O P H O S P H A M I D 178 T E M O Z O L O M I D / I R I N O T E C A N 1 7 8 1 5 . 3 O S T E O S A R K O M EURO-B.O.S.S.-STUDIE 1 7 9 D O X O R U B I C I N / I F O S F A M I D 1 7 6 IMAGE 4 X INHALTSVERZEICHNIS 1 6 Z N S - T U M O R E N 1 8 3 L O M U S T I N 1 0 6 T E M O Z O L O M I D 1 8 4 HIT2OOO/NOA-O7 1 8 4 B E V A C I Z U M A B / I R I N O T E C A N 185 1 7 U N B E K A N N T E R P R I M AE R T U M O R 1 8 7 PCE 1 8 8 TEIL III INTRAKAVITAERE CHEMOTHERAPIE LIQUORINSTILLATION A R A C / D E X A M E T H A S O N / M T X T H E R A P I E . . . . 1 9 0 L I Q U O R I N S T I L L A T I O N A R A C / D E X A M E T H A S O N / M T X PROPHYLAXE, PAT. 55J 1 9 0 L I Q U O R I N S T I L L A T I O N A R A C / D E X A M E T H A S O N / M T X P R O P H Y L A X E , PAT. 5 5 J 1 9 1 L I Q U O R I N S T I L L A T I O N M T X - M O N O 191 L I P O S O M A L E S ARAC 1 9 2 B L E O M Y C I N I N T R A P E R I K A R D I A L 1 9 2 TEIL IV MOBILISIERUNGSCHEMOTHERAPIEN TEIL VI ALLOGENE KONDITIONIERUNGSPROTOKOLLE BUSULFAN/CYCLOPHOSPHAMID 208 F L U D A R A B I N / B U S U L F A N 2 0 9 F L U D A R A B I N / C A R M U S T I N / M E L P H A L A N ( 55J.) 2 0 8 F L U D A R A B I N / C A R M U S T I N / M E L P H A L A N ( 55J.) 2 0 9 F L U D A R A B I N / T H I O T E P A 2 1 0 C A R M U S T I N / F L U D A R A B I N / T H I O T E P A (BFT) 2 1 1 H D C Y C L O P H O S P H A M I D / F L U D A R A B I N 2 1 0 T B I / E T O P O S I D P H O S O P H A T 2 1 1 F L U D A R A B I N / T R E O S U L F A N + CYA/MTX/(ATG) 2 1 2 TEIL VII SUPPORTIVE THERAPIEPROTOKOLLE ALEMTUZUMAB I.V. B E I G V H D 2 1 4 A N T I E M E S E B E I H O C H E M E T O G E N E R C H E M O T H E R A P I E (HEC) . . . 2 1 4 A N T I E M E S E B E I M O D E R A T E M E T O G E N E R C H E M O T H E R A P I E (MEC) 2 1 5 S T A N D A R D 2 1 5 S O N D E R F A L L : A N T H R A C Y C L I N + C Y C L O P H O S P H A M I D 215 VCP-E 1 9 4 VIP-E 1 9 4 I N D 1 C Y C L O P H O S P H A M I D 195 C Y C L O - M O B - 1 D 195 C Y C L O - M O B - 2 D 1 9 6 DEXA-BEAM 1 9 6 IEV ( 60J.) 1 9 7 IEV ( 60J.) 1 9 7 EVC B E I N I E R E N I N S U F F I Z I E N Z ( 60J.) 1 9 8 EVC B E I N I E R E N I N S U F F I Z I E N Z ( 60J.) 1 9 8 VC 1 9 9 TEILV AUTOLOGE KONDITIONIERUNGS- PROTOKOLLE VIC 2 0 2 CCT 2 0 2 BEAM 2 0 3 B M ( 66J.) 2 0 3 TBI/ARAC/MEL M C L - Y O U N G E R - S T U D I E A R M B 5 2 M E L P H A L A N 2 0 0 2 0 4 M E L P H A L A N 140 2 0 5 B C N U / T H I O T E P A 2 0 6 B U S U L F A N / C Y C L O P H O S P H A M I D 2 0 4 B U S U L F A N M O N O P.O 2 0 5 B U S U L F A N M O N O I.V 2 0 6
any_adam_object	1
author	Engelhardt, Monika 1966- Berger, Dietmar Paul Mertelsmann, Roland 1944-
author_GND	(DE-588)113263538 (DE-588)111674808 (DE-588)122802187
author_facet	Engelhardt, Monika 1966- Berger, Dietmar Paul Mertelsmann, Roland 1944-
author_role	aut aut aut
author_sort	Engelhardt, Monika 1966-
author_variant	m e me d p b dp dpb r m rm
building	Verbundindex
bvnumber	BV040132483
classification_rvk	XH 3209
ctrlnum	(OCoLC)794526237 (DE-599)DNB1012630765
dewey-full	616.994061
dewey-hundreds	600 - Technology (Applied sciences)
dewey-ones	616 - Diseases
dewey-raw	616.994061
dewey-search	616.994061
dewey-sort	3616.994061
dewey-tens	610 - Medicine and health
discipline	Medizin
edition	4. Aufl.
format	Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV040132483</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130725</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">120514s2012 ad\|\| \|\|\|\| 00\|\|\| ger d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">11,N24</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1012630765</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642206252</subfield><subfield code="9">978-3-642-20625-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3642206255</subfield><subfield code="9">3-642-20625-5</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783642206252</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)794526237</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1012630765</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994061</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3209</subfield><subfield code="0">(DE-625)152888:12915</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QZ 267</subfield><subfield code="2">nlm</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">840</subfield><subfield code="2">rpb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Engelhardt, Monika</subfield><subfield code="d">1966-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)113263538</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Das Blaue Buch</subfield><subfield code="b">Chemotherapie-Manual Hämatologie und internistische Onkologie ; mit CD-ROM</subfield><subfield code="c">Monika Engelhardt ; Dietmar Berger ; Roland Mertelsmann</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">4. Aufl.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXIV, 215 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield><subfield code="e">1 CD-ROM (12 cm)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Antineoplastic Protocols</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Neoplasms - drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Antineoplastic Agents - therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Hematologic Neoplasms - drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">CD-ROM</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Antineoplastic Protocols</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Neoplasms</subfield><subfield code="a">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Antineoplastic Agents</subfield><subfield code="a">therapeutic use</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hämatologie</subfield><subfield code="0">(DE-588)4022796-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Onkologie</subfield><subfield code="0">(DE-588)4075658-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Onkologie</subfield><subfield code="0">(DE-588)4075658-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Hämatologie</subfield><subfield code="0">(DE-588)4022796-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Onkologie</subfield><subfield code="0">(DE-588)4075658-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Hämatologie</subfield><subfield code="0">(DE-588)4022796-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berger, Dietmar Paul</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)111674808</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mertelsmann, Roland</subfield><subfield code="d">1944-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)122802187</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">X:MVB</subfield><subfield code="q">text/html</subfield><subfield code="u">http://deposit.dnb.de/cgi-bin/dokserv?id=3838623&prov=M&dok_var=1&dok_ext=htm</subfield><subfield code="3">Inhaltstext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024989611&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-024989611</subfield></datafield></record></collection>
id	DE-604.BV040132483
illustrated	Illustrated
indexdate	2024-07-21T00:32:30Z
institution	BVB
isbn	9783642206252 3642206255
language	German
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-024989611
oclc_num	794526237
open_access_boolean
owner	DE-355 DE-BY-UBR
owner_facet	DE-355 DE-BY-UBR
physical	XXIV, 215 S. Ill., graph. Darst. 1 CD-ROM (12 cm)
publishDate	2012
publishDateSearch	2012
publishDateSort	2012
publisher	Springer
record_format	marc
spelling	Engelhardt, Monika 1966- Verfasser (DE-588)113263538 aut Das Blaue Buch Chemotherapie-Manual Hämatologie und internistische Onkologie ; mit CD-ROM Monika Engelhardt ; Dietmar Berger ; Roland Mertelsmann 4. Aufl. Berlin [u.a.] Springer 2012 XXIV, 215 S. Ill., graph. Darst. 1 CD-ROM (12 cm) txt rdacontent n rdamedia nc rdacarrier Antineoplastic Protocols Neoplasms - drug therapy Antineoplastic Agents - therapeutic use Hematologic Neoplasms - drug therapy CD-ROM Neoplasms drug therapy Antineoplastic Agents therapeutic use Cytostatikum (DE-588)4068347-3 gnd rswk-swf Hämatologie (DE-588)4022796-0 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Chemotherapie (DE-588)4127083-6 gnd rswk-swf Onkologie (DE-588)4075658-0 gnd rswk-swf Onkologie (DE-588)4075658-0 s Hämatologie (DE-588)4022796-0 s Chemotherapie (DE-588)4127083-6 s Cytostatikum (DE-588)4068347-3 s 1\p DE-604 Krebs Medizin (DE-588)4073781-0 s 2\p DE-604 Berger, Dietmar Paul Verfasser (DE-588)111674808 aut Mertelsmann, Roland 1944- Verfasser (DE-588)122802187 aut X:MVB text/html http://deposit.dnb.de/cgi-bin/dokserv?id=3838623&prov=M&dok_var=1&dok_ext=htm Inhaltstext DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024989611&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk
spellingShingle	Engelhardt, Monika 1966- Berger, Dietmar Paul Mertelsmann, Roland 1944- Das Blaue Buch Chemotherapie-Manual Hämatologie und internistische Onkologie ; mit CD-ROM Antineoplastic Protocols Neoplasms - drug therapy Antineoplastic Agents - therapeutic use Hematologic Neoplasms - drug therapy CD-ROM Neoplasms drug therapy Antineoplastic Agents therapeutic use Cytostatikum (DE-588)4068347-3 gnd Hämatologie (DE-588)4022796-0 gnd Krebs Medizin (DE-588)4073781-0 gnd Chemotherapie (DE-588)4127083-6 gnd Onkologie (DE-588)4075658-0 gnd
subject_GND	(DE-588)4068347-3 (DE-588)4022796-0 (DE-588)4073781-0 (DE-588)4127083-6 (DE-588)4075658-0
title	Das Blaue Buch Chemotherapie-Manual Hämatologie und internistische Onkologie ; mit CD-ROM
title_auth	Das Blaue Buch Chemotherapie-Manual Hämatologie und internistische Onkologie ; mit CD-ROM
title_exact_search	Das Blaue Buch Chemotherapie-Manual Hämatologie und internistische Onkologie ; mit CD-ROM
title_full	Das Blaue Buch Chemotherapie-Manual Hämatologie und internistische Onkologie ; mit CD-ROM Monika Engelhardt ; Dietmar Berger ; Roland Mertelsmann
title_fullStr	Das Blaue Buch Chemotherapie-Manual Hämatologie und internistische Onkologie ; mit CD-ROM Monika Engelhardt ; Dietmar Berger ; Roland Mertelsmann
title_full_unstemmed	Das Blaue Buch Chemotherapie-Manual Hämatologie und internistische Onkologie ; mit CD-ROM Monika Engelhardt ; Dietmar Berger ; Roland Mertelsmann
title_short	Das Blaue Buch
title_sort	das blaue buch chemotherapie manual hamatologie und internistische onkologie mit cd rom
title_sub	Chemotherapie-Manual Hämatologie und internistische Onkologie ; mit CD-ROM
topic	Antineoplastic Protocols Neoplasms - drug therapy Antineoplastic Agents - therapeutic use Hematologic Neoplasms - drug therapy CD-ROM Neoplasms drug therapy Antineoplastic Agents therapeutic use Cytostatikum (DE-588)4068347-3 gnd Hämatologie (DE-588)4022796-0 gnd Krebs Medizin (DE-588)4073781-0 gnd Chemotherapie (DE-588)4127083-6 gnd Onkologie (DE-588)4075658-0 gnd
topic_facet	Antineoplastic Protocols Neoplasms - drug therapy Antineoplastic Agents - therapeutic use Hematologic Neoplasms - drug therapy CD-ROM Neoplasms drug therapy Antineoplastic Agents therapeutic use Cytostatikum Hämatologie Krebs Medizin Chemotherapie Onkologie
url	http://deposit.dnb.de/cgi-bin/dokserv?id=3838623&prov=M&dok_var=1&dok_ext=htm http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024989611&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv	AT engelhardtmonika dasblauebuchchemotherapiemanualhamatologieundinternistischeonkologiemitcdrom AT bergerdietmarpaul dasblauebuchchemotherapiemanualhamatologieundinternistischeonkologiemitcdrom AT mertelsmannroland dasblauebuchchemotherapiemanualhamatologieundinternistischeonkologiemitcdrom

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Beschreibung

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge